What does the soluble transferrin receptor test indicate and how is it used to distinguish iron‑deficiency anemia from anemia of chronic disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Soluble Transferrin Receptor (sTfR) Test

Soluble transferrin receptor (sTfR) is elevated in iron deficiency and remains unaffected by inflammation, making it the superior test for distinguishing iron-deficiency anemia from anemia of chronic disease when ferritin is unreliable due to inflammatory conditions. 1

What sTfR Indicates

sTfR reflects two key physiological states:

  • Tissue iron deficiency - When cells lack iron, they upregulate transferrin receptors on their surface, leading to increased sTfR in serum
  • Erythropoietic activity - Increased red blood cell production also raises sTfR levels

The critical advantage: sTfR is NOT an acute phase reactant, unlike ferritin which falsely elevates during inflammation, infection, or chronic disease 2, 1.

Clinical Application: Distinguishing IDA from Anemia of Chronic Disease

The Diagnostic Challenge

When evaluating anemia with inflammation present, ferritin becomes unreliable because it rises as an acute phase reactant. This creates a diagnostic dilemma where:

  • TSAT may be <20% in both conditions
  • Ferritin may be 100-700 ng/mL (or higher) in both conditions 3

How to Use sTfR

In iron deficiency anemia:

  • sTfR is elevated (typically >2.5-3.0 mg/L depending on assay) 2, 4
  • Remains high even when inflammation is present

In pure anemia of chronic disease:

  • sTfR is normal or low 2, 1
  • Iron is trapped in reticuloendothelial cells but not truly deficient

In combined conditions (ACD + IDA):

  • sTfR is elevated, indicating coexistent true iron deficiency 5
  • This is the scenario where sTfR provides maximum clinical value

The sTfR/log Ferritin Index: Superior Discrimination

The sTfR/log ferritin index outperforms either test alone, particularly in chronic disease 2. This ratio:

  • Provides superior discrimination with AUC of 0.87-0.994 6, 7
  • Is especially valuable in the "ferritin grey zone" (10-100 ng/mL) where diagnosis is most difficult 7
  • More than doubles IDA detection from 41% (ferritin alone) to 92% (when using ferritin, sTfR, and sTfR index together) 6

Practical Diagnostic Algorithm

When ferritin is <45 ng/mL without inflammation:

  • Iron deficiency is present; sTfR not needed 2

When ferritin is 45-150 ng/mL with inflammation or chronic disease:

  1. Order sTfR
  2. If sTfR elevated → Iron deficiency present (treat with iron)
  3. If sTfR normal → Pure anemia of chronic disease (treat underlying condition)
  4. Calculate sTfR/log ferritin index for enhanced accuracy 2, 1

When ferritin is >150 ng/mL:

  • Iron deficiency unlikely even with inflammation 2
  • If TSAT <20%, consider functional iron deficiency or inflammatory block 3, 1

Important Caveats and Limitations

When sTfR Can Be Falsely Elevated (Not Iron Deficiency):

  • Hemolytic anemias - increased erythropoietic drive 2
  • Thalassemias - ineffective erythropoiesis 2
  • Recent response to IV iron - stimulated erythropoiesis 1
  • Hemoglobin E disease 2

Practical Limitations:

  • Not routinely available in most hospitals 2, 1
  • Long turnaround time when sent to reference labs 1
  • Different assay methods have different cutoff values - chemiluminescent (2.91 mg/L), immunoturbidimetric (6.70 mg/L), immunonephelometric (2.48 mg/L) 4
  • Not useful in infants <1 year - may remain normal despite iron deficiency 8

Performance Characteristics

Based on meta-analysis of 18 studies 9:

  • Sensitivity: 86% for detecting iron deficiency
  • Specificity: 75%
  • Positive likelihood ratio: 3.85
  • Negative likelihood ratio: 0.19
  • AUC: 0.912

The sTfR index performs even better with AUC of 0.87-0.994 in various studies 6, 7.

Alternative Tests When sTfR Unavailable

If sTfR is not available, consider:

  • Reticulocyte hemoglobin content (CHr or RET-He) - directly assesses functional iron availability, immediately available on certain analyzers (Siemens, Sysmex) 1
  • Percent hypochromic red cells - >10% indicates iron deficiency, requires specialized equipment 3
  • Empiric trial of IV iron - give 50-125 mg weekly for 8-10 doses; if no erythropoietic response, inflammatory block is present rather than true iron deficiency 3

References

Related Questions

Is the soluble transferrin receptor (sTfR) to log ferritin ratio superior to using either test alone for distinguishing iron‑deficiency anemia from anemia of chronic disease in patients with chronic inflammatory disease?
What are the possible causes and recommended work‑up for a patient with low hematocrit, low red blood cell count, low hemoglobin, and elevated serum iron, total iron‑binding capacity (TIBC) and unsaturated iron‑binding capacity (UIBC)?
What does a high transferrin level indicate and how is it treated?
How to diagnose Anemia of Chronic Disease (ACD) with a normal Red Blood Cell (RBC) count?
What does a low serum transferrin level of 189 indicate and how is it treated?
In a 61‑year‑old woman with a lipoprotein(a) level of 216 nmol/L, can this value alone reclassify her into the very‑high cardiovascular risk category?
What is the recommended asthma management protocol for an adult patient in Australia for a GP, including diagnosis confirmation, initial low‑dose inhaled corticosteroid (ICS) therapy, step‑up to a combination inhaler with long‑acting β2‑agonist (LABA), a personalized asthma action plan, and treatment of acute exacerbations?
Can fexofenadine 60 mg once daily be switched to loratadine 10 mg once daily for a patient?
In a 10-year-old with a radial shaft stress fracture, bone‑marrow edema, and radial nerve neurapraxia, what is the role of oral corticosteroids in management?
What are the Australian guidelines for managing an acute asthma exacerbation in adults, including discharge criteria and indications for referral versus self‑management?
When should total iron‑binding capacity (TIBC) be ordered in the evaluation of anemia, and how does it help differentiate iron‑deficiency anemia from anemia of chronic disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.